{"acute kidney injury": 2.41, "acute myeloid leukaemia": 22.07, "adverse event": 26.76, "aspergillus infection": 37.04, "bronchopulmonary aspergillosis": 44.4, "cholestasis": 12.88, "death": 6.46, "drug interaction": 4.72, "drug level below therapeutic": 52.31, "drug level decreased": 31.92, "drug level increased": 10.28, "drug-induced liver injury": 10.7, "electrocardiogram qt prolonged": 13.24, "febrile neutropenia": 3.75, "fungal infection": 8.51, "gamma-glutamyltransferase increased": 3.92, "graft versus host disease": 34.15, "hepatic cytolysis": 16.71, "hepatic enzyme increased": 3.93, "hepatic function abnormal": 3.2, "hepatotoxicity": 10.51, "hyperbilirubinaemia": 13.24, "hypokalaemia": 19.03, "inappropriate schedule of product administration": 2.41, "incorrect dose administered": 3.38, "infection": 2.76, "leukaemia": 18.11, "liver injury": 5.09, "myelodysplastic syndrome": 10.17, "neutropenia": 2.04, "pancytopenia": 2.01, "pneumonia fungal": 61.58, "product prescribing error": 8.37, "product use in unapproved indication": 4.69, "product use issue": 6.01, "rash maculo-papular": 4.19, "renal failure": 2.1, "renal impairment": 2.32, "rhabdomyolysis": 2.36, "sepsis": 3.0, "septic shock": 4.22, "therapeutic product ineffective": 40.99}